title: The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?
authors.affiliation: Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University , Istanbul , Turkey.
authors.forename: Ahmet Emre
authors.initials: AE
authors.lastname: Eskazan
authors.forename: Muhlis Cem
authors.initials: MC
authors.lastname: Ar
authors.forename: Teoman
authors.initials: T
authors.lastname: Soysal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents